StockVS

Transcat, Inc. (TRNS) Stock Analysis

Industrials

Transcat, Inc.

$76.45

+$3.43 (+4.70%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Transcat, Inc. operates as a provider of calibration and laboratory instrument services, serving clients across the United States, Canada, and international markets through its specialized business services model. The company functions within the Industrials sector and specifically within the Specialty Business Services industry, a classification that highlights its niche focus on technical instrumentation rather than broad manufacturing or consumer goods. Its operational scale is defined by a market capitalization of $681.44M, annual revenue of $319.69M, and an employee base of 1245 individuals. These valuation and revenue figures indicate that Transcat holds a substantial position within its niche, supported by a workforce sufficient to maintain a global footprint of service and distribution operations. The combination of significant market cap and multi-million dollar revenue stream suggests the company has established a durable business model capable of generating substantial operating cash flows despite its specific industry constraints.

Financial Health

Transcat reported revenue of $319.69M over the trailing twelve months, with a corresponding net income of $7.89M and EBITDA of $41.33M. The substantial gap between the $319.69M in revenue and the $7.89M in net income reveals a cost structure characterized by significant operating expenses that absorb a large portion of top-line growth. The company generated $25.09M in free cash flow, which provides it with considerable financial flexibility to fund operations, service existing debt, or pursue strategic initiatives without relying heavily on external financing. Profitability analysis shows a gross margin of 32.5%, an operating margin of 1.0%, and a profit margin of 2.5%, indicating that while the company maintains healthy gross efficiency, its ability to convert revenue into operating profit is tightly constrained by overhead costs. Regarding liquidity and leverage, Transcat holds $3.47M in cash against $134.00M in total debt, resulting in a debt-to-equity ratio of 45.15, which suggests a balance sheet that is leveraged rather than conservative. The current ratio stands at 2.21, a metric that indicates the company possesses more than double the liquid assets required to cover its short-term liabilities, pointing to robust short-term liquidity management. Finally, the return on equity is 2.7% and the return on assets is 2.4%, metrics that reveal management effectiveness is currently limited in generating high returns on the capital base relative to the high valuation multiples often seen in the sector.

Valuation Assessment

The valuation of Transcat, Inc. is characterized by a trailing P/E ratio of 85.91 and a forward P/E of 35.36. The significant difference between these two metrics implies that the market expects a dramatic improvement in earnings trajectory over the coming year, as the forward multiple is less than half the trailing multiple. The price-to-book ratio is recorded at 2.30, which indicates that the market prices the company at more than double its book value, suggesting a premium assigned to its intangible assets, brand, or service franchise. Alternative valuation metrics provide further context, with a price-to-sales ratio of 2.13 and an EV/EBITDA of 19.01, suggesting the company is valued based on a combination of revenue generation and cash-flow-adjacent earnings rather than purely historical profitability. The stock has traded between a 52-week high of $97.08 and a 52-week low of $50.23, and given the forward P/E of 35.36 versus the trailing P/E of 85.91, the current market pricing suggests the stock is likely trading significantly below its recent 52-week high while having recovered from the low end of its annual range. The beta value of 0.69 indicates that the stock exhibits lower price volatility relative to the broader market, moving with less intensity than the overall index.

Growth & Income

Transcat has demonstrated robust top-line expansion with revenue growth of 25.6% year-over-year, while earnings growth is listed as N/A. The absence of reported earnings growth data prevents a direct comparison of whether earnings are growing faster or slower than revenue, though the high revenue expansion suggests a period of scaling operations. As a non-dividend payer, the company does not distribute a dividend yield or maintain a payout ratio, indicating a strategy of reinvesting earnings into growth initiatives rather than providing income to shareholders. This reinvestment approach is typical for companies in the growth phase of their lifecycle, where capital is retained to expand service networks and distribution channels. The overall growth and income profile is defined by aggressive revenue expansion and a capital retention strategy, prioritizing business scaling over immediate shareholder income distribution.

Peer Comparison

Transcat, Inc. (TRNS) operates in the Specialty Business Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Transcat, Inc. TRNS $713.45M 134.1
Cintas Corporation CTAS $68.46B 36.1
RELX PLC RELX $58.35B 21.9
Thomson Reuters Corporation TRI.TO $50.46B 24.1

The Specialty Business Services industry average P/E ratio is 65.9x. Transcat, Inc. trades at a P/E of 134.1.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Transcat, Inc.

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control, and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value-added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense, industrial manufacturing, energy and utilities, chemical manufacturing, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.

Visit website →

Key Statistics

Market Cap
$713.45M
P/E Ratio
134.12
52-Week High
$93.20
52-Week Low
$50.23
Avg Volume
134.59K

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
United States